GEN

Evaluating Immunomodulation Therapeutics in Translationally-Relevant Humanized Mice

Understanding the interactions between human immune cells and tumors is paramount when devising treatment strategies that prevent tumor evasion by immune cells and improve cytotoxic responses. However ...
Healio

EULAR, ACR: Likely HLH/MAS should be met with immunomodulation while diagnosis continues

Please provide your email address to receive an email when new articles are posted on . The points to consider advise beginning immunomodulatory therapy while diagnostic investigations continue.
Healio

Half of long COVID patients form ‘inflammatory subset,’ may benefit from immunomodulation

Please provide your email address to receive an email when new articles are posted on . Half of patients with long COVID demonstrate persistent inflammation and may potentially benefit from ...
ascopubs.org

Immunomodulation of pembrolizumab (pembro) treated metastatic melanoma patients (pts) after progression with sequential temozolomide (TMZ): A case series.

GRM1 to induce M-CSF and CCL2 expression to lead to an upregulation of M2 macrophages in melanoma. This is an ASCO Meeting Abstract from the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium. This ...
ascopubs.org

Immunomodulation by HDAC inhibition: Results from a phase II study with entinostat and high-dose Interleukin 2 in renal cell carcinoma patients (CTEP#7870).

Subgroup analyses of METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients (pts) with advanced renal cell carcinoma (RCC). This is an ASCO Meeting Abstract from the 2016 ...